Amar, 2000 | 2.9 (1.7) | 57 | 10 | CVD Mortality | Ischemic heart disease, Stroke, Aortoiliac disease, Congestive heart failure, Sudden death | Age, Gender, Prior CVD | Not Tested |
Fagard,
a
2000 | | 695 | 79 | CVD Morbidity and Mortality | Sudden death, Stroke, MI, Heart failure | Gender, Prior CVD | Not Tested |
| 29 | Stroke | Neurologic deficit lasting >24 hours or causing death | | |
Gosse, 1997 | 2.5 (0.7) | 134 | 14 | CVD Morbidity and Mortality | Stroke, MI, Angina, Heart failure, Renal failure, Lower limb arterial disease | | ABP better than Clinic BP, by discriminant function analyses |
Nakano, 1999 | 4.2 | 257 | 22 | Dialysis | Incident hemodialysis | Age, Gender, Smoking, Blood pressure, Glycemic control, Duration of diabetes, Serum protein, Serum creatinine. | ABP better than Clinic BP, by stepwise regression analyses |
Ohkubo,
b
1997a | 5.1 (2) | 1542 | 93 | Total Mortality | Total mortality | Age, Gender, Smoking, Anti hypertensive medications, Prior CVD | Not tested |
| 37 | CVD Mortality | CVD Mortality | | |
Ohkubo,
b
1997b | 5.1 (2) | 1542 | 93 | Total Mortality | Total mortality | Age, Gender, Smoking, Anti hypertensive medications, Prior CVD | ABP better than Clinic BP, by stepwise regression analyses |
| 37 | CVD Mortality | CVD Mortality | | |
Ohkubo,
b
2000 | 6.4 (2) | 1476 | 74 | Stroke | Stroke or TIA | Age, Gender, Smoking, Cholesterol, Hematocrit, Prior CVD, Diabetes, BP medication | ABP better than Clinic BP, by stepwise regression analyses |
Perloff, 1989 | 5.5 (3.5) | 761 | 120 | CVD Morbidity and Mortality | Cardiac, Cerebral and peripheral vascular diseases, Aortic dissection, Retinal vascular changes, Renal function decline, Heart failure | Age, Gender, LVH, BP medication, Optic fundus. | Incremental Gain of ABP over clinic BP, by residual model |
Redon, 1998 | 4 | 86 | 21 | CVD Morbidity and Mortality | MI, Angina, Coronary Revascularization, Stroke, TIA, Sudden death, Aortoiliac occlusive disease, Heart failure, Hypertensive emergencies | Prior CVD | ABP better than Clinic BP, by stepwise regression analyses |
Staessen,
a
1999 | 4.4 [median] | 265 | 39 | Total Mortality | Total mortality | Age, Gender, Smoking, Prior CVD | Incremental Gain of ABP over clinic BP, by regression analyses with both variables entered in models |
| 22 | CVD Mortality | CVD mortality | | |
54 | CVD Morbidity and Mortality | Fatal and Non fatal heart failure, MI, Sudden death, Stroke | | |
20 | Stroke | Fatal and non fatal stroke | | |
35 | Cardiac Morbidity and Mortality | Fatal and non fatal heart failure, MI | | |
Suzuki, 2000 | 4.3 (1.8) | 134 | 34 | CVD Morbidity and Mortality | MI, Angina, Cerebral infarction, Cerebral hemorrhage, TIA, Sudden death, Heart failure, Renal failure | Age, Gender, Smoking, Diabetes, LVH, Prior CVD | ABP better than Clinic BP, by stepwise regression analyses |
Verdecchia,
c
1994 | 3.2 | 1392 | 89 | CVD Morbidity and Mortality | MI, Stroke, Sudden death, Heart failure, Stroke, TIA, Coronary revascularization, Angina, Ischemic changes on ECG, Aortoiliac occlusive disease, Retinal artery occlusion, Renal failure | Age, Diabetes, Prior CVD, Pulse Pressure, Clinic DBP, Smoking, Cholesterol, BMI, LVH | Not tested |
Verdecchia,
c
1998 | 3.8 (2.4) | 2010 | 36 | CVD Morbidity and Mortality | New onset coronary artery disease, Stroke, TIA, Aortoiliac occlusive disease, Retinal artery occlusion, Heart failure, Renal failure | Age, Gender, Smoking, BMI, Smoking, Cholesterol, BP medications, LVH | ABP better than Clinic BP, by stepwise regression analyses |
Zweiker, 1994 | 2.6 | 116 | 4 | Total Mortality | Total mortality | | Not tested |
| 5 | CVD Morbidity and Mortality | MI, Apoplexy, TIA | | |